RGEN
Repligen Corp
Price:  
118.85 
USD
Volume:  
769,906.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RGEN EV/EBITDA

-98.1%
Upside

As of 2025-06-23, the EV/EBITDA ratio of Repligen Corp (RGEN) is -138.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. RGEN's latest enterprise value is 6,509.37 mil USD. RGEN's TTM EBITDA according to its financial statements is -46.89 mil USD. Dividing these 2 quantities gives us the above RGEN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 12.8x - 16.8x 14.4x
Forward P/E multiples 19.1x - 22.6x 20.1x
Fair Price (7.72) - 14.95 2.29
Upside -106.5% - -87.4% -98.1%
118.85 USD
Stock Price
2.29 USD
Fair Price

RGEN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-06-18 -137.26
2025-06-17 -141.42
2025-06-16 -147.51
2025-06-13 -149.22
2025-06-12 -153.75
2025-06-11 -154.59
2025-06-10 -155.63
2025-06-09 -154.21
2025-06-06 -150.16
2025-06-05 -148.24
2025-06-04 -148.06
2025-06-03 -145.48
2025-06-02 -138.50
2025-05-30 -137.90
2025-05-29 -142.99
2025-05-28 -141.63
2025-05-27 -143.26
2025-05-23 -138.00
2025-05-22 -140.75
2025-05-21 -140.46
2025-05-20 -149.31
2025-05-19 -147.63
2025-05-16 -148.00
2025-05-15 -144.12
2025-05-14 -149.85
2025-05-13 -154.05
2025-05-12 -156.65
2025-05-09 -144.09
2025-05-08 -149.62
2025-05-07 -148.46
2025-05-06 -152.67
2025-05-05 -165.28
2025-05-02 -165.99
2025-05-01 -160.82
2025-04-30 -161.77
2025-04-29 -163.49
2025-04-28 -168.53
2025-04-25 -169.87
2025-04-24 -170.44
2025-04-23 -165.85
2025-04-22 -162.89
2025-04-21 -154.16
2025-04-17 -152.19
2025-04-16 -154.71
2025-04-15 -148.14
2025-04-14 -148.91
2025-04-11 -143.64
2025-04-10 -134.45
2025-04-09 -144.83
2025-04-08 -126.90